Welcome Guest | Register / Login

Global Healthcare CMO Market: Trends & Opportunities (2015-2020)

Table of Contents

1. Executive Summary

2. Introduction
2.1 Healthcare CMOs
2.1.1 Pharmaceutical CMOs
2.1.2 Medical Device CMOs
2.2 Pharmaceutical Outsourcing
2.3 Pharmaceutical CMOs v/s CDMOs

3. Global Healthcare CMO Market: An Analysis
3.1 Global Healthcare CMO Market: Sizing and Growth
3.1.1 Global Healthcare CMO Market by Value
3.1.2 Global Healthcare CMO Market by Segments
3.2 Global Medical Device CMO Market: Sizing and Growth
3.2.1 Global Medical Device CMO Market by Value
3.2.2 Global Medical Device CMO Market by Players
3.2.3 Global Medical Device CMO Market by Cost Structure
3.3 Global Pharmaceutical CMO Market: Sizing and Growth
3.3.1 Global Pharmaceutical CMO Market by Value
3.3.2 Global Pharmaceutical CMO Market by Segments
3.4 Global Active Pharmaceutical Ingredient (API) CMO Market: Sizing and Growth
3.4.1 Global Active Pharmaceutical Ingredient CMO Market by Value
3.5 Global Finished Dosage Formulation (FDF) CMO Market: Sizing and Growth
3.5.1 Global Finished Dosage Formulation CMO Market by Value
3.5.2 Global Finished Dosage Formulation CMO Market by Revenue Structure
3.5.3 Global Finished Dosage Formulation CMO Market by Geographical Approach
3.5.4 Global Finished Dosage Formulation CMO Market by Dose Formulation

4. Global Pharmaceutical CDMO Market: An Analysis
4.1 Global Pharmaceutical CDMO Market: Sizing and Growth
4.1.1 Global Pharmaceutical CDMO Market by Value
4.1.2 Global Pharmaceutical CDMO Market by Geography
4.1.3 Global Pharmaceutical CDMO Market by Players
4.2 Global Pharmaceutical CDMO Market: A Regional Analysis
4.2.1 USA’s Pharmaceutical CDMO Market by Value
4.2.2 European Pharmaceutical CDMO Market by Value
4.2.3 China’s Pharmaceutical CDMO Market by Value
4.2.4 Indian Pharmaceutical CDMO Market by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Growth in Global Pharmaceutical Industry
5.1.2 Drug Plants Divested by Big Pharmaceutical Companies
5.1.3 Outsourced Production
5.1.4 NMEs Requiring Special Handling
5.2 Challenges
5.2.1 Highly Fragmented Market
5.2.2 Less Preference for Outsourcing of Profitable Drugs
5.2.3 Manufacturing of Biological Drugs Less Outsourced
5.2.4 Investment in Own Production Facilities by Pharmaceutical Companies
5.3 Market Trends
5.3.1 Increased reliance on CMO/CDMO services
5.3.2 Innovation
5.3.3 Increased Regulatory Pressure on Quality
5.3.4 Change in Cost Base of Big Pharmaceutical Companies
5.3.5 Dosage Forms likely to be outsourced

6. Competitive Landscape

7. Company Profiles
7.1 Catalent Pharma Solutions Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Recipharm
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Aurobindo Pharma Limited
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

List of Tables

Table 1: Financial Comparison of Players in Global Healthcare CMO Market; 2014

List of Figures

Figure 1: Healthcare CMO Market by Segments
Figure 2: Pharmaceutical Outsourcing by Segments
Figure 3: Value Chain of a Drug
Figure 4: Global Healthcare CMO Market by Value; 2012-2014 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Value; 2015-2020 (US$ Billion)
Figure 6: Global Healthcare CMO Market by Segments; 2014
Figure 7: Global Medical Device CMO Market by Value; 2012-2014 (US$ Billion)
Figure 8: Global Medical Device CMO Market by Value; 2015-2020 (US$ Billion)
Figure 9: Global Medical Device CMO Market by Players; 2014E
Figure 10: Global Medical Device CMO Market by Cost Structure; 2014
Figure 11: Global Pharmaceutical CMO Market by Value; 2012-2014 (US$ Billion)
Figure 12: Global Pharmaceutical CMO Market by Value; 2015-2020 (US$ Billion)
Figure 13: Global Pharmaceutical CMO Market by Segments; 2014
Figure 14: Global Active Pharmaceutical Ingredient CMO Market by Value; 2013-2020E (US$ Billion)
Figure 15: Global Finished Dosage Formulation CMO Market by Value; 2009-2014 (US$ Billion)
Figure 16: Global Finished Dosage Formulation CMO Market by Value; 2015-2020 (US$ Billion)
Figure 17: Global Finished Dosage Formulation CMO Market by Revenue Structure; 2014
Figure 18: Global Finished Dosage Formulation CMO Market by Geographical Approach; 2014
Figure 19: Global Finished Dosage Formulation CMO Market by Dose Formulation; 2014
Figure 20: Global Pharmaceutical CDMO Market by Value; 2011-2014 (US$ Billion)
Figure 21: Global Pharmaceutical CDMO Market by Value; 2015-2019 (US$ Billion)
Figure 22: Global Pharmaceutical CDMO Market Share by Geography; 2014
Figure 23: Global Pharmaceutical CDMO Market Growth by Geography; 2011-2015 (CAGR, %)
Figure 24: Global Pharmaceutical CDMO Market Players by Sales Range; 2014 (US$ Million)
Figure 25: Global Pharmaceutical CDMO Market Players by Geography; 2014
Figure 26: USA’s Pharmaceutical CDMO Market by Value; 2011-2014 (US$ Billion)
Figure 27: USA’s Pharmaceutical CDMO Market by Value; 2015-2020 (US$ Billion)
Figure 28: European Pharmaceutical CDMO Market by Value; 2011-2014 (US$ Billion)
Figure 29: European Pharmaceutical CDMO Market by Value; 2015-2020 (US$ Billion)
Figure 30: China’s Pharmaceutical CDMO Market by Value; 2011-2014 (US$ Billion)
Figure 31: China’s Pharmaceutical CDMO Market by Value; 2015-2020 (US$ Billion)
Figure 32: Indian Pharmaceutical CDMO Market by Value; 2011-2014 (US$ Billion)
Figure 33: Indian Pharmaceutical CDMO Market by Value; 2015-2020 (US$ Billion)
Figure 34: Global Pharmaceutical Industry; 2007-2014 (US$ Billion)
Figure 35: Drug Plants Divested; 2000-2013 (avg.)
Figure 36: Outsourced Production; 2014
Figure 37: NME’s Approved and Outsourced; 2010-2014
Figure 38: Investment in Own Production Facilities by Pharmaceutical Companies; 2010-2014 (US$ Million)
Figure 39: Dosage Forms likely to be outsourced; 2014-2015
Figure 40: Catalent Pharma Solutions, Inc. Net Revenue; 2009-2014 (US$ Million)
Figure 41: Catalent Pharma Solutions Inc. Revenue by Segments; 2014
Figure 42: Recipharm Business Overview
Figure 43: Recipharm Net Sales; 2010-2014 (US$ Million)
Figure 44: Recipharm Net Sales by Segments; 2014
Figure 45: Recipharm Net Sales by Customers; 2014
Figure 46: Aurobindo Pharma Ltd. Revenue; 2010-2014 (US$ Million)
Figure 47: Aurobindo Pharma Ltd. Revenue by Segments; 2014
Figure 48: Aurobindo Pharma Ltd. Revenue by Geography

Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Corporate/Global User License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Daedal Research
Price